Decker Retirement Planning’s Inovio Pharmaceuticals INO Stock Holding History

Decker Retirement Planning’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$185	Buy	+168	New	+$199	﹤0.01%	429

Other funds holding INO

Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

MJT & Associates Financial Advisory Monteviceo, Minnesota $151M AUM 22.54% 1-Year Est. Return

Pioneer Family Office North Miami Beach, Florida $194M AUM

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Blume Capital Management Berkeley, California $684M AUM 41.68% 1-Year Est. Return

Decker Retirement Planning's INO Position: Q2 2026 in Review

Decker Retirement Planning opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 168 shares worth $185. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings.

23 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Decker Retirement Planning held 168 shares of Inovio Pharmaceuticals worth $185 as of Q2 2026.
Inovio Pharmaceuticals was a new Decker Retirement Planning position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Decker Retirement Planning's portfolio in Q2 2026, its #429 holding.
23 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.